Skip to content

Prediction of Progression Risk in Hypertensive Disorders of Pregnancy Based on Retinal Imaging and sFlt-1/PlGF Ratio

Prediction of Progression Risk in Hypertensive Disorders of Pregnancy Based on Retinal Imaging and sFlt-1/PlGF Ratio

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115782
Enrollment
Unknown
Registered
2025-12-31
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertensive Disorders of Pregnancy

Interventions

Low sFlt-1/PIGF ratio group=38:NA

Sponsors

Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Singleton pregnancy; 2. 20 to 41 weeks of gestation; 3. Hospitalized patients diagnosed with hypertensive disorders of pregnancy; 4. Aged >= 18 years old; 5. Underwent simultaneous sFlt-1/PlGF testing; 6. Clinical uncertainty regarding the severity of their disease and likely progression; 7. Provided written informed consent; 8. Underwent fundus photography.

Exclusion criteria

Exclusion criteria: 1. Patients with overt hemolysis, elevated liver enzymes, and low platelet count (HELLP syndrome) or those with fulminant signs and/or symptoms of PE; 2. History of eye surgery, cataract, or severe refractive media opacity; 3. Severe systemic diseases; 4. Severe systemic diseases or severe psychiatric disorders, Major fetal anomalies detected at recruitment; 5. Patients with a high likelihood of being lost to follow-up.

Design outcomes

Primary

MeasureTime frame
Disease progression within 1–4 weeks of sFlt-1/PlGF testing;

Secondary

MeasureTime frame
Incidence of adverse outcomes in mother and infant;The proportion of pregnancies terminated due to hypertension;Usage rate of antihypertensive drugs and glucocorticoids;

Countries

China

Contacts

Public ContactCui Ying

Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences)

cuiying-sysu@163.com+86 18665639687

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026